Select status:
Sort by:
Filter by consultation end date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and October 2021

Filter by area of interest
Filter by type
Showing 1 to 10 of 19
Title Consultation Type Consultation end date
Fedratinib for disease-related splenomegaly and symptoms in myelofibrosis [ID1501] Appraisal consultation Technology appraisal guidance Type:28 July 2021 20210728
Berotralstat for preventing acute attacks of hereditary angioedema [ID1624] Appraisal consultation Technology appraisal guidance Type:28 July 2021 20210728
Pembrolizumab with chemotherapy and surgery for treating resectable gastric or gastro-oesophageal junction cancer [ID2696] Appraisal consultation Technology appraisal guidance Type:29 July 2021 20210729
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID3928] Appraisal consultation Technology appraisal guidance Type:30 July 2021 20210730
OTL-200 for treating metachromatic leukodystrophy [ID1666] Evaluation consultation Highly specialised technology Type:30 July 2021 20210730
Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy [ID3892] Appraisal consultation Technology appraisal guidance Type:02 August 2021 20210802
Metastatic spinal cord compression in adults: risk assessment, diagnosis and management Draft scope consultation NICE guideline Type:02 August 2021 20210802
Belimumab for treating lupus nephritis [ID2722] Appraisal consultation Technology appraisal guidance Type:03 August 2021 20210803
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea Diagnostics consultation Diagnostics guidance Type:04 August 2021 20210804
Tobacco: preventing uptake, promoting quitting and treating dependence (update) Draft guidance consultation NICE guideline Type:06 August 2021 20210806